LTGH.F Stock Overview
Operates as a private healthcare company in Southern Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Life Healthcare Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R0.54 |
| 52 Week High | R1.00 |
| 52 Week Low | R0.51 |
| Beta | 0.23 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -79.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| LTGH.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 2.2% |
| 1Y | n/a | 2.1% | 31.6% |
Return vs Industry: Insufficient data to determine how LTGH.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how LTGH.F performed against the US Market.
Price Volatility
| LTGH.F volatility | |
|---|---|
| LTGH.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LTGH.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LTGH.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Peter Wharton-Hood | www.lifehealthcare.co.za |
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates as a private healthcare company in Southern Africa. It also operates as a research and development pharmaceutical company in the United Kingdom, Europe, the United States, and internationally. The company operates acute hospitals.
Life Healthcare Group Holdings Limited Fundamentals Summary
| LTGH.F fundamental statistics | |
|---|---|
| Market cap | US$1.01b |
| Earnings (TTM) | US$77.25m |
| Revenue (TTM) | US$1.30b |
13.1x
P/E Ratio0.8x
P/S RatioIs LTGH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LTGH.F income statement (TTM) | |
|---|---|
| Revenue | R23.76b |
| Cost of Revenue | R17.13b |
| Gross Profit | R6.63b |
| Other Expenses | R5.22b |
| Earnings | R1.41b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 20, 2024
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 27.89% |
| Net Profit Margin | 5.93% |
| Debt/Equity Ratio | 33.1% |
How did LTGH.F perform over the long term?
See historical performance and comparison